
Luis A. Pérez-Romasanta/X
May 4, 2025, 13:12
Luis A. Pérez-Romasanta: DART phase II trial results
Luis A. Pérez-Romasanta, Radiation Oncologist affiliated with Salamanca University Hospital, shared a post on X:
“ESTRO25 PROSTATE:
- DART phase II trial(oligomets PSMA+).
- SBRT+/-Darolutamide.
- Tox & QL results.”
More posts featuring ESTRO25 on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 4, 2025, 13:12
May 4, 2025, 12:59
May 4, 2025, 12:58
May 4, 2025, 12:45
May 4, 2025, 12:33
May 4, 2025, 11:14